{"id":47693,"date":"2022-08-26T12:01:55","date_gmt":"2022-08-26T10:01:55","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/microrna-mirna-global-market-report-2022-increasing-incidence-of-infectious-diseases-and-chronic-conditions-to-drive-growth-researchandmarkets-com\/"},"modified":"2022-08-26T12:01:55","modified_gmt":"2022-08-26T10:01:55","slug":"microrna-mirna-global-market-report-2022-increasing-incidence-of-infectious-diseases-and-chronic-conditions-to-drive-growth-researchandmarkets-com","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/microrna-mirna-global-market-report-2022-increasing-incidence-of-infectious-diseases-and-chronic-conditions-to-drive-growth-researchandmarkets-com\/","title":{"rendered":"microRNA (miRNA) Global Market Report 2022: Increasing Incidence of Infectious Diseases and Chronic Conditions to Drive Growth – ResearchAndMarkets.com"},"content":{"rendered":"
\n

DUBLIN–(BUSINESS WIRE)–The “microRNA (miRNA) – Global Market Trajectory & Analytics”<\/a> report has been added to ResearchAndMarkets.com’s<\/strong> offering.\n<\/p>\n

<\/a><\/p>\n

\nGlobal microRNA (miRNA) Market to Reach $485.3 Million by 2026<\/strong>\n<\/p>\n

\nKey drivers propelling growth in the global microRNA market include greater awareness, increasing emphasis on R&D activities, growth of advanced and well-organized technology, rising government initiatives globally, escalating government investments in healthcare, along with advances in genomic technologies and molecular biology.\n<\/p>\n

\nThe growth of microRNA in oncology can be attributed to the growing burden of cancer as well as other cardiovascular diseases, broader therapeutic applications, lowering the cost of sequencing, and greater acceptance of the technology. Rising microRNA adoption in emerging countries such as India, China, among others will offer new growth opportunities.\n<\/p>\n

\nThe growing use of microRNA biomarkers is augmenting growth in the market. Such biomarkers play a particularly important role in data-driven approaches, genome-wide population-based studies because they show high reproducibility and robustness in comparison to conventional procedures. Furthermore, the growing relevance of liquid biopsies is further driving its popularity in the discovery and development of biomarkers. However, intensified demand for highly skilled personnel and challenges regarding in-house development are major hurdles to growth in the global market.\n<\/p>\n

\nAmid the COVID-19 crisis, the global market for microRNA (miRNA) estimated at US$282.6 Million in the year 2022, is projected to reach a revised size of US$485.3 Million by 2026, growing at a CAGR of 13.8% over the analysis period.\n<\/p>\n

\nThe U.S. Market is Estimated at $120.5 Million in 2022, While China is Forecast to Reach $50.7 Million by 2026<\/strong>\n<\/p>\n

\nThe microRNA (miRNA) market in the U.S. is estimated at US$120.5 Million in the year 2022. China, the world’s second largest economy, is forecast to reach a projected market size of US$50.7 Million by the year 2026 trailing a CAGR of 17.7% over the analysis period. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 12.1% and 13% respectively over the analysis period.\n<\/p>\n

\nKey Topics Covered:<\/strong>\n<\/p>\n

\nI. METHODOLOGY<\/strong>\n<\/p>\n

\nII. EXECUTIVE SUMMARY<\/strong>\n<\/p>\n

\n1. MARKET OVERVIEW<\/strong>\n<\/p>\n

\n2. FOCUS ON SELECT PLAYERS<\/strong>\n<\/p>\n

\n3. MARKET TRENDS & DRIVERS<\/strong>\n<\/p>\n